2012 || Product Pipeline Review
38 views | +0 today
Follow
2012 || Product Pipeline Review
Related to Pharmaceuticals and Healthcare
Curated by Lavanya
Your new post is loading...
Your new post is loading...
Scooped by Lavanya
Scoop.it!

2013 U.S. Department Stores Industry,Industry & Market Report, Market Research Reports

2013 U.S. Department Stores Industry,Industry & Market Report, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
2013 U.S. Department Stores Industry,Industry & Market Report
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

2011 U.S. Computer & Equipment Wholesale Industry Report, Market Research Reports

2011 U.S. Computer & Equipment Wholesale Industry Report, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
2011 U.S. Computer & Equipment Wholesale Industry Report
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

Bacillus Infections – Pipeline Review, H2 2012, Market Research Reports

Bacillus Infections – Pipeline Review, H2 2012, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
Bacillus Infections – Pipeline Review, H2 2012
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

Follicular Thyroid Cancer – Pipeline Review, H2 2012, Market Research Reports

Follicular Thyroid Cancer – Pipeline Review, H2 2012, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
Follicular Thyroid Cancer – Pipeline Review, H2 2012
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

Hypoparathyroidism – Pipeline Review, H2 2012, Market Research Reports

Hypoparathyroidism – Pipeline Review, H2 2012, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
Hypoparathyroidism – Pipeline Review, H2 2012
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

Neuralgia – Pipeline Review, H2 2012 | Market Research Reports

Neuralgia – Pipeline Review, H2 2012 | Market Research Reports | 2012 || Product Pipeline Review | Scoop.it

Global Markets Direct’s, Neuralgia - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline...

Neuralgia – Pipeline Review, H2 2012

http://www.aarkstore.com/reports/Neuralgia-Pipeline-Review-H2-2012-236071.html



Published Date : 28 November 2012
Pages : 147
$ 2000 - PDF $ 4000 - Site Licence $ 6000 - Corporate Licence

Inquiry/Sample Request


Summary

Global Markets Direct’s, Neuralgia - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Neuralgia, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Neuralgia. Neuralgia - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Neuralgia.
- A review of the Neuralgia products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Neuralgia pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Neuralgia.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding Neuralgia pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.


Table of Contents :

List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Neuralgia Overview 11
Therapeutics Development 12
An Overview of Pipeline Products for Neuralgia 12
Neuralgia Therapeutics under Development by Companies 14
Neuralgia Therapeutics under Investigation by Universities/Institutes 18
Late Stage Products 20
Comparative Analysis 20
Mid Clinical Stage Products 21
Comparative Analysis 21
Early Clinical Stage Products 22
Comparative Analysis 22
Discovery and Pre-Clinical Stage Products 23
Comparative Analysis 23
Neuralgia Therapeutics – Products under Development by Companies 24
Neuralgia Therapeutics – Products under Investigation by Universities/Institutes 25
Companies Involved in Neuralgia Therapeutics Development 26
Bristol-Myers Squibb Company 26
DURECT Corporation 27
Kyowa Hakko Kirin Co., Ltd. 28
Abbott Laboratories 29
Allergan, Inc. 30
Sanofi-Aventis 31
Daewoong Pharmaceutical Co., Ltd. 32
Pfizer Inc. 33
Merck KGaA 34

 

Reports of Pipeline Review, H2 2012

  Erosive Oral Lichen Planus – Pipeline Review, H2 2012   Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012   Blepharitis – Pipeline Review, H2 2012   Hypoparathyroidism – Pipeline Review, H2 2012   Lyme Disease – Pipeline Review, H2 2012   Optic Nerve Injury – Pipeline Review, H2 2012   Auto Inflammatory Disease – Pipeline Review, H2 2012   West Nile Virus Infections – Pipeline Review, H2 2012   Hypereosinophilic Syndrome – Pipeline Review, H2 2012   Gastroenteritis – Pipeline Review, H2 2012   Gingivitis – Pipeline Review, H2 2012   Bacteremia – Pipeline Review, H2 2012   Cellulite – Pipeline Review, H2 2012

 

 

For More details about above & other Reports plz contact :


Lavanya
Aarkstore.com

Contact: Marketing team
Mob.No.918149852585
Email: enquiry@aarkstore.com , discount@aarkstore.com
URL: http://www.aarkstore.com/
http://in.linkedin.com/in/aarkstore
http://www.facebook.com/aarkstore

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

2012 || Product Pipeline || e-Therapeutics plc – Product Pipeline Review – 2012 || Aarkstore.com

2012 || Product Pipeline || e-Therapeutics plc – Product Pipeline Review – 2012 || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Market Direct’s pharmaceuticals report, “e-Therapeutics plc - Product
Pipeline Review - 2012” provides data on the e-Therapeutics plc’s research and
development focus.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

e-Therapeutics plc – Product Pipeline Review – 2012   http://www.aarkstore.com/reports/e-Therapeutics-plc-Product-Pipeline-Review-2012-228143.html


 You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Market Direct’s pharmaceuticals report, “e-Therapeutics plc - Product Pipeline Review - 2012” provides data on the e-Therapeutics plc’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- e-Therapeutics plc - Brief e-Therapeutics plc overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of e-Therapeutics plc human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.

Reasons to buy

- Evaluate e-Therapeutics plc’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of e-Therapeutics plc in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the e-Therapeutics plc’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

Table of contents:

List of Tables 3
List of Figures 3
Etubics Corporation Snapshot 4
Etubics Corporation Overview 4
Key Information 4
Key Facts 4
Etubics Corporation – Research and Development Overview 5
Key Therapeutic Areas 5
Etubics Corporation – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
Etubics Corporation – Pipeline Products Glance 9
Etubics Corporation Clinical Stage Pipeline Products 9
Phase II Products/Combination Treatment Modalities 9
Phase I Products/Combination Treatment Modalities 10
Etubics Corporation – Early Stage Pipeline Products 11
Pre-Clinical Products/Combination Treatment Modalities 11
Discovery Products/Combination Treatment Modalities 12
Etubics Corporation – Drug Profiles 13
Breast Cancer Vaccine 13


List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1
 

 

Etubics Corporation – Product Pipeline Review – 2012

Faron Pharmaceuticals Oy – Product Pipeline Review – 2012

D. Western Therapeutics Institute, Inc. – Product Pipeline Review – 2012

Deciphera Pharmaceuticals, LLC – Product Pipeline Review – 2012

Dr. Falk Pharma GmbH – Product Pipeline Review – 2012

Eiger BioPharmaceuticals, Inc. – Product Pipeline Review – 2012

e-Therapeutics plc – Product Pipeline Review – 2012

FIT Biotech Oyj – Product Pipeline Review – 2012

Gamida Cell Ltd. – Product Pipeline Review – 2012


 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1







For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

2012 || Product Pipeline || Dr. Falk Pharma GmbH – Product Pipeline Review – 2012 || Aarkstore.com

2012 || Product Pipeline || Dr. Falk Pharma GmbH – Product Pipeline Review – 2012 || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Market Direct’s pharmaceuticals report, “Dr. Falk Pharma GmbH - Product
Pipeline Review - 2012” provides data on the Dr. Falk Pharma GmbH’s research and
development focus.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Dr. Falk Pharma GmbH – Product Pipeline Review – 2012 http://www.aarkstore.com/reports/Dr-Falk-Pharma-GmbH-Product-Pipeline-Review-2012-228141.html


 You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Market Direct’s pharmaceuticals report, “Dr. Falk Pharma GmbH - Product Pipeline Review - 2012” provides data on the Dr. Falk Pharma GmbH’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


Scope

- Dr. Falk Pharma GmbH - Brief Dr. Falk Pharma GmbH overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Dr. Falk Pharma GmbH human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.

Reasons to buy

- Evaluate Dr. Falk Pharma GmbH’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Dr. Falk Pharma GmbH in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Dr. Falk Pharma GmbH’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.


Table of contents:

List of Tables 3
List of Figures 3
Eiger BioPharmaceuticals, Inc. Snapshot 4
Eiger BioPharmaceuticals, Inc. Overview 4
Key Information 4
Key Facts 4
Eiger BioPharmaceuticals, Inc. – Research and Development Overview 5
Key Therapeutic Areas 5
Eiger BioPharmaceuticals, Inc. – Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products – Monotherapy 8
Eiger BioPharmaceuticals, Inc. – Pipeline Products Glance 9
Eiger BioPharmaceuticals, Inc. Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Eiger BioPharmaceuticals, Inc. – Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Eiger BioPharmaceuticals, Inc. – Drug Profiles 11
clemizole 11
Product Description 11
Mechanism of Action 11


List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1
 

 

Etubics Corporation – Product Pipeline Review – 2012

Faron Pharmaceuticals Oy – Product Pipeline Review – 2012

D. Western Therapeutics Institute, Inc. – Product Pipeline Review – 2012

Deciphera Pharmaceuticals, LLC – Product Pipeline Review – 2012

Dr. Falk Pharma GmbH – Product Pipeline Review – 2012

Eiger BioPharmaceuticals, Inc. – Product Pipeline Review – 2012

e-Therapeutics plc – Product Pipeline Review – 2012

FIT Biotech Oyj – Product Pipeline Review – 2012

Gamida Cell Ltd. – Product Pipeline Review – 2012


 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1







For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

2012 || Product Pipeline || D. Western Therapeutics Institute, Inc. – Product || Aarkstore.com

2012 || Product Pipeline || D. Western Therapeutics Institute, Inc. – Product || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Market Direct’s pharmaceuticals report, “D. Western Therapeutics
Institute, Inc. - Product Pipeline Review - 2012” provides data on the D.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

D. Western Therapeutics Institute, Inc. – Product Pipeline Review – 2012


http://www.aarkstore.com/reports/D-Western-Therapeutics-Institute-Inc-Product-Pipeline-Review-2012-228139.html

 You can also request for sample page of above mention reports on sample@aarkstore.com


Summary

Global Market Direct’s pharmaceuticals report, “D. Western Therapeutics Institute, Inc. - Product Pipeline Review - 2012” provides data on the D. Western Therapeutics Institute, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


Scope

- D. Western Therapeutics Institute, Inc. - Brief D. Western Therapeutics Institute, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of D. Western Therapeutics Institute, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.

Reasons to buy

- Evaluate D. Western Therapeutics Institute, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of D. Western Therapeutics Institute, Inc. in its therapy areas of focus.

Table of contents:

List of Tables 4
List of Figures 4
Deciphera Pharmaceuticals, LLC Snapshot 5
Deciphera Pharmaceuticals, LLC Overview 5
Key Information 5
Key Facts 5
Deciphera Pharmaceuticals, LLC – Research and Development Overview 6
Key Therapeutic Areas 6
Deciphera Pharmaceuticals, LLC – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Deciphera Pharmaceuticals, LLC – Pipeline Products Glance 11
Deciphera Pharmaceuticals, LLC Clinical Stage Pipeline Products 11
Phase I Products/Combination Treatment Modalities 11
Deciphera Pharmaceuticals, LLC – Early Stage Pipeline Products 12
Pre-Clinical Products/Combination Treatment Modalities 12
Discovery Products/Combination Treatment Modalities 13
Deciphera Pharmaceuticals, LLC – Drug Profiles 14
cFMS Kinase Program 14


List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1
 

 

Etubics Corporation – Product Pipeline Review – 2012

Faron Pharmaceuticals Oy – Product Pipeline Review – 2012

D. Western Therapeutics Institute, Inc. – Product Pipeline Review – 2012

Deciphera Pharmaceuticals, LLC – Product Pipeline Review – 2012

Dr. Falk Pharma GmbH – Product Pipeline Review – 2012

Eiger BioPharmaceuticals, Inc. – Product Pipeline Review – 2012

e-Therapeutics plc – Product Pipeline Review – 2012

FIT Biotech Oyj – Product Pipeline Review – 2012

Gamida Cell Ltd. – Product Pipeline Review – 2012


 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1







For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

H2 2012 || Pipeline || Multiple Myeloma (Kahlers Disease) – Pipeline Review || Aarkstore.com

H2 2012 || Pipeline || Multiple Myeloma (Kahlers Disease) – Pipeline Review || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Markets Direct’s, Multiple Myeloma (Kahlers Disease) - Pipeline Review,
H2 2012, provides an overview of the indication’s therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Multiple-Myeloma-Kahlers-Disease-Pipeline-Review-H2-2012-228044.html


You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Markets Direct’s, Multiple Myeloma (Kahlers Disease) - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Multiple Myeloma (Kahlers Disease), complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Multiple Myeloma (Kahlers Disease). Multiple Myeloma (Kahlers Disease) - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Multiple Myeloma (Kahlers Disease).
- A review of the Multiple Myeloma (Kahlers Disease) products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Multiple Myeloma (Kahlers Disease).
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 8
List of Figures 13
Introduction 14
Global Markets Direct Report Coverage 14
Multiple Myeloma (Kahlers Disease) Overview 15
Therapeutics Development 16
An Overview of Pipeline Products for Multiple Myeloma (Kahlers Disease) 16
Multiple Myeloma (Kahlers Disease) Therapeutics under Development by Companies 18
Multiple Myeloma (Kahlers Disease) Therapeutics under Investigation by Universities/Institutes 27
Late Stage Products 39
Comparative Analysis 39
Mid Clinical Stage Products 40
Comparative Analysis 40
Early Clinical Stage Products 41
Comparative Analysis 41
Discovery and Pre-Clinical Stage Products 42
Comparative Analysis 42
Multiple Myeloma (Kahlers Disease) Therapeutics – Products under Development by Companies 43
Multiple Myeloma (Kahlers Disease) Therapeutics – Products under Investigation by Universities/Institutes 56
Companies Involved in Multiple Myeloma (Kahlers Disease) Therapeutics Development 87
Bristol-Myers Squibb Company 87
Johnson & Johnson 88
Kyowa Hakko Kirin Co., Ltd. 89
Abbott Laboratories 90
Amgen Inc. 91
Eli Lilly and Company 92
Viralytics Ltd. 93
GlaxoSmithKline plc 94
Seattle Genetics, Inc. 95
Genentech, Inc. 96


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:


Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1

 

Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012

Respiratory Depression – Pipeline Review, H2 2012

Metastatic Cancer – Pipeline Review, H2 2012

Viral Infections – Pipeline Review, H2 2012

Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
 

  Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

  Diabetes – Pipeline Review, H2 2012

  Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

  Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012

  Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

  Malaria – Pipeline Review, H2 2012

  Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012

  Dermatitis – Pipeline Review, H2 2012

 

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 


For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

H2 2012 || Pipeline || Metastatic Cancer – Pipeline Review, H2 2012 || Aarkstore.com

H2 2012 || Pipeline || Metastatic Cancer – Pipeline Review, H2 2012 || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Markets Direct’s, Metastatic Cancer - Pipeline Review, H2 2012,
provides an overview of the indication’s therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Metastatic Cancer – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Metastatic-Cancer-Pipeline-Review-H2-2012-228041.html You can also request for sample page of above mention reports on sample@aarkstore.com  

Summary

Global Markets Direct’s, Metastatic Cancer - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Metastatic Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Metastatic Cancer. Metastatic Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Metastatic Cancer.
- A review of the Metastatic Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.


Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Metastatic Cancer.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 20
List of Figures 24
Introduction 25
Global Markets Direct Report Coverage 25
Metastatic Cancer Overview 26
Therapeutics Development 27
An Overview of Pipeline Products for Metastatic Cancer 27
Metastatic Cancer Therapeutics under Development by Companies 29
Metastatic Cancer Therapeutics under Investigation by Universities/Institutes 43
Metastatic Cancer Therapeutics – Products under Development by Companies 67
Metastatic Cancer Therapeutics – Products under Investigation by Universities/Institutes 97
Companies Involved in Metastatic Cancer Therapeutics Development 150
Bristol-Myers Squibb Company 150
Johnson & Johnson 151
Boehringer Ingelheim GmbH 152
F. Hoffmann-La Roche Ltd. 153
Kyowa Hakko Kirin Co., Ltd. 154
Celsion Corporation 155
Abbott Laboratories 156
Vical Incorporated 157
Amgen Inc. 158
Sanofi-Aventis 159
Adherex Technologies Inc. 160
AstraZeneca PLC 161
Eli Lilly and Company 162
Viralytics Ltd. 163
GlaxoSmithKline plc 164
Tekmira Pharmaceuticals Corp. 165
Bionovo, Inc. 223
Cytokinetics, Inc 224
Telik, Inc. 225


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:


Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1

 

Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012

Respiratory Depression – Pipeline Review, H2 2012

Metastatic Cancer – Pipeline Review, H2 2012

Viral Infections – Pipeline Review, H2 2012

Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
 

  Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

  Diabetes – Pipeline Review, H2 2012

  Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

  Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012

  Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

  Malaria – Pipeline Review, H2 2012

  Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012

  Dermatitis – Pipeline Review, H2 2012

 

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 


For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

H2 2012 || Pipeline Review || Dengue – Pipeline Review, H2 2012 || Aarkstore.com

H2 2012 || Pipeline Review || Dengue – Pipeline Review, H2 2012 || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Markets Direct’s, Dengue - Pipeline Review, H2 2012, provides an
overview of the indication’s therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Dengue – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Dengue-Pipeline-Review-H2-2012-227980.html You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Markets Direct’s, Dengue - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Dengue, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Dengue. Dengue - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Dengue.
- A review of the Dengue products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.


Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Dengue.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Dengue Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Dengue 11
Dengue Therapeutics under Development by Companies 13
Dengue Therapeutics under Investigation by Universities/Institutes 16
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21
Dengue Therapeutics – Products under Development by Companies 22
Dengue Therapeutics – Products under Investigation by Universities/Institutes 23
Companies Involved in Dengue Therapeutics Development 24
Vical Incorporated 24
GenVec, Inc. 25
Merck & Co., Inc. 26
Biotron Limited 27
Alfacell Corporation 28
AVI BioPharma Inc. 29
Medivir AB 30
NanoViricides, Inc. 31
SIGA Technologies, Inc. 32
MacroGenics, Inc. 33
Canopus BioPharma Incorporated 34
GenPhar, Inc. 35
Ikaria Inc. 36



List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:


Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1

 

Neutropenia – Pipeline Review, H2 2012

Amyloidosis – Pipeline Review, H2 2012

Human Papillomavirus Infections – Pipeline Review, H2 2012

Cancer Pain – Pipeline Review, H2 2012

Dengue – Pipeline Review, H2 2012

 

  Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

  Diabetes – Pipeline Review, H2 2012

  Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

  Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012

  Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

  Malaria – Pipeline Review, H2 2012

  Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012

  Dermatitis – Pipeline Review, H2 2012

 

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 


For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

H2 2012 || Pipeline Review || Human Papillomavirus Infections – Pipeline Review || Aarkstore.com

H2 2012 || Pipeline Review || Human Papillomavirus Infections – Pipeline Review || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Markets Direct’s, Human Papillomavirus Infections - Pipeline Review, H2
2012, provides an overview of the indication’s therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Human Papillomavirus Infections – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Human-Papillomavirus-Infections-Pipeline-Review-H2-2012-227978.html
You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Markets Direct’s, Human Papillomavirus Infections - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Human Papillomavirus Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Human Papillomavirus Infections. Human Papillomavirus Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Human Papillomavirus Infections.
- A review of the Human Papillomavirus Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Human Papillomavirus Infections.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Human Papillomavirus Infections Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Human Papillomavirus Infections 11
Human Papillomavirus Infections Therapeutics under Development by Companies 13
Human Papillomavirus Infections Therapeutics under Investigation by Universities/Institutes 17
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21
Human Papillomavirus Infections Therapeutics – Products under Development by Companies 22
Human Papillomavirus Infections Therapeutics – Products under Investigation by Universities/Institutes 23
Companies Involved in Human Papillomavirus Infections Therapeutics Development 24
Helix BioPharma Corp. 24
Valeant Pharmaceuticals International 25
Inovio Biomedical Corporation 26
Merck & Co., Inc. 27
MediGene AG 28


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:


Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1

 

Neutropenia – Pipeline Review, H2 2012

Amyloidosis – Pipeline Review, H2 2012

Human Papillomavirus Infections – Pipeline Review, H2 2012

Cancer Pain – Pipeline Review, H2 2012

Dengue – Pipeline Review, H2 2012

 

  Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

  Diabetes – Pipeline Review, H2 2012

  Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

  Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012

  Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

  Malaria – Pipeline Review, H2 2012

  Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012

  Dermatitis – Pipeline Review, H2 2012

 

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 


For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

2012 U.S. Beer & Wine & Liquor Stores Industry,Industry & Market Report, Market Research Reports

2012 U.S. Beer & Wine & Liquor Stores Industry,Industry & Market Report, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
2012 U.S. Beer & Wine & Liquor Stores Industry,Industry & Market Report
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

2013 U.S. Drinking Places & Bars Industry,Industry & Market Report, Market Research Reports

2013 U.S. Drinking Places & Bars Industry,Industry & Market Report, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
2013 U.S. Drinking Places & Bars Industry,Industry & Market Report
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

Other Cancer – Pipeline Review, H2 2012, Market Research Reports

Other Cancer – Pipeline Review, H2 2012, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
Other Cancer – Pipeline Review, H2 2012
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

Colorectal Cancer – Pipeline Review, H2 2012, Market Research Reports

Colorectal Cancer – Pipeline Review, H2 2012, Market Research Reports | 2012 || Product Pipeline Review | Scoop.it
Colorectal Cancer – Pipeline Review, H2 2012
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

Bookmarklet | Scoop.it

Bookmarklet | Scoop.it | 2012 || Product Pipeline Review | Scoop.it
Shine on the web
Lavanya's insight:

http://www.aarkstore.com/reports/Medical-Devices-Market-in-China-to-2018-Government-Reforms-Aimed-at-Strengthening-the-Healthcare-System-and-Expanding-Access-will-Accelerate-Growth-231930.html

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

Pipeline Review, H2 2012 | Market research report

Pipeline Review, H2 2012 | Market research report | 2012 || Product Pipeline Review | Scoop.it
  Hereditary Angioedema (HAE) – Pipeline Review, H2 2012   Dermatomycoses – Pipeline Review, H2 2012   Familial Adenomatous Polyposis Coli – Pipeline Review, H2 2012   Tinnitus – Pipeline Review, H2 2012   Premenstrual Syndrome – Pipeline Review, H2 2012   Wrinkles – Pipeline Review, H2 2012   Genital Warts (Condylomata Acuminata) – Pipeline Review, H2 2012   Fabry Disease – Pipeline Review, H2 2012   Thyroid Gland Disorders – Pipeline Review, H2 2012   Proteinuria – Pipeline Review, H2 2012   Viral Conjunctivitis – Pipeline Review, H2 2012   Mixed Dyslipidemia – Pipeline Review, H2 2012   Keratitis – Pipeline Review, H2 2012   Generalized Seizures – Pipeline Review, H2 2012   Cataract – Pipeline Review, H2 2012   Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2 2012   Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012   Erosive Oral Lichen Planus – Pipeline Review, H2 2012   Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012   Blepharitis – Pipeline Review, H2 2012   Hypoparathyroidism – Pipeline Review, H2 2012   Lyme Disease – Pipeline Review, H2 2012   Optic Nerve Injury – Pipeline Review, H2 2012   Auto Inflammatory Disease – Pipeline Review, H2 2012   West Nile Virus Infections – Pipeline Review, H2 2012   Hypereosinophilic Syndrome – Pipeline Review, H2 2012   Gastroenteritis – Pipeline Review, H2 2012   Gingivitis – Pipeline Review, H2 2012   Bacteremia – Pipeline Review, H2 2012   Cellulite – Pipeline Review, H2 2012

 

  Hereditary Angioedema (HAE) – Pipeline Review, H2 2012   Dermatomycoses – Pipeline Review, H2 2012   Familial Adenomatous Polyposis Coli – Pipeline Review, H2 2012   Tinnitus – Pipeline Review, H2 2012   Premenstrual Syndrome – Pipeline Review, H2 2012   Wrinkles – Pipeline Review, H2 2012   Genital Warts (Condylomata Acuminata) – Pipeline Review, H2 2012   Fabry Disease – Pipeline Review, H2 2012   Thyroid Gland Disorders – Pipeline Review, H2 2012   Proteinuria – Pipeline Review, H2 2012   Viral Conjunctivitis – Pipeline Review, H2 2012   Mixed Dyslipidemia – Pipeline Review, H2 2012   Keratitis – Pipeline Review, H2 2012   Generalized Seizures – Pipeline Review, H2 2012   Cataract – Pipeline Review, H2 2012   Hyperphosphatemia In Chronic Kidney Disease – Pipeline Review, H2 2012   Thrombocythaemia Myelofibrosis – Pipeline Review, H2 2012   Erosive Oral Lichen Planus – Pipeline Review, H2 2012   Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H2 2012   Blepharitis – Pipeline Review, H2 2012   Hypoparathyroidism – Pipeline Review, H2 2012   Lyme Disease – Pipeline Review, H2 2012   Optic Nerve Injury – Pipeline Review, H2 2012   Auto Inflammatory Disease – Pipeline Review, H2 2012   West Nile Virus Infections – Pipeline Review, H2 2012   Hypereosinophilic Syndrome – Pipeline Review, H2 2012   Gastroenteritis – Pipeline Review, H2 2012   Gingivitis – Pipeline Review, H2 2012   Bacteremia – Pipeline Review, H2 2012   Cellulite – Pipeline Review, H2 2012
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

2012 || Product Pipeline || Eiger BioPharmaceuticals, Inc. – Product Pipeline || Aarkstore.com

2012 || Product Pipeline || Eiger BioPharmaceuticals, Inc. – Product Pipeline || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Market Direct’s pharmaceuticals report, “Eiger BioPharmaceuticals, Inc. -
Product Pipeline Review - 2012” provides data on the Eiger BioPharmaceuticals,
Inc.’s research and development focus.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Eiger BioPharmaceuticals, Inc. – Product Pipeline Review – 2012 http://www.aarkstore.com/reports/Eiger-BioPharmaceuticals-Inc-Product-Pipeline-Review-2012-228142.html


 You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Market Direct’s pharmaceuticals report, “Eiger BioPharmaceuticals, Inc. - Product Pipeline Review - 2012” provides data on the Eiger BioPharmaceuticals, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.


Scope

- Eiger BioPharmaceuticals, Inc. - Brief Eiger BioPharmaceuticals, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Eiger BioPharmaceuticals, Inc. human therapeutic division.

Reasons to buy

- Evaluate Eiger BioPharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Eiger BioPharmaceuticals, Inc. in its therapy areas of focus.

Table of contents:

List of Tables 5
List of Figures 5
e-Therapeutics plc Snapshot 6
e-Therapeutics plc Overview 6
Key Information 6
Key Facts 6
e-Therapeutics plc – Research and Development Overview 7
Key Therapeutic Areas 7
e-Therapeutics plc – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
e-Therapeutics plc – Pipeline Products Glance 12
e-Therapeutics plc – Late Stage Pipeline 12
Phase III Products/Combination Treatment Modalities 12
e-Therapeutics plc Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
e-Therapeutics plc – Early Stage Pipeline Products 15
Pre-Clinical Products/Combination Treatment Modalities 15
Discovery Products/Combination Treatment Modalities 16
e-Therapeutics plc – Drug Profiles 17
ETS-2101 17


List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1
 

 

Etubics Corporation – Product Pipeline Review – 2012

Faron Pharmaceuticals Oy – Product Pipeline Review – 2012

D. Western Therapeutics Institute, Inc. – Product Pipeline Review – 2012

Deciphera Pharmaceuticals, LLC – Product Pipeline Review – 2012

Dr. Falk Pharma GmbH – Product Pipeline Review – 2012

Eiger BioPharmaceuticals, Inc. – Product Pipeline Review – 2012

e-Therapeutics plc – Product Pipeline Review – 2012

FIT Biotech Oyj – Product Pipeline Review – 2012

Gamida Cell Ltd. – Product Pipeline Review – 2012


 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1







For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

2012 || Product Pipeline || Deciphera Pharmaceuticals, LLC – Product Pipeline || Aarkstore.com

2012 || Product Pipeline || Deciphera Pharmaceuticals, LLC – Product Pipeline || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Market Direct’s pharmaceuticals report, “Deciphera Pharmaceuticals, LLC -
Product Pipeline Review - 2012” provides data on the Deciphera Pharmaceuticals,
LLC’s research and development focus.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Deciphera Pharmaceuticals, LLC – Product Pipeline Review – 2012 http://www.aarkstore.com/reports/Deciphera-Pharmaceuticals-LLC-Product-Pipeline-Review-2012-228140.html


 You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Market Direct’s pharmaceuticals report, “Deciphera Pharmaceuticals, LLC - Product Pipeline Review - 2012” provides data on the Deciphera Pharmaceuticals, LLC’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

Scope

- Deciphera Pharmaceuticals, LLC - Brief Deciphera Pharmaceuticals, LLC overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Deciphera Pharmaceuticals, LLC human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.

Reasons to buy

- Evaluate Deciphera Pharmaceuticals, LLC’s strategic position with total access to detailed information on its product pipeline.
- Assess the growth potential of Deciphera Pharmaceuticals, LLC in its therapy areas of focus.
- Identify new drug targets and therapeutic classes in the Deciphera Pharmaceuticals, LLC’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.

Table of contents:

List of Tables 4
List of Figures 4
Dr. Falk Pharma GmbH Snapshot 5
Dr. Falk Pharma GmbH Overview 5
Key Information 5
Key Facts 5
Dr. Falk Pharma GmbH – Research and Development Overview 6
Key Therapeutic Areas 6
Dr. Falk Pharma GmbH – Pipeline Review 9
Pipeline Products by Stage of Development 9
Pipeline Products – Monotherapy 10
Pipeline Products – Combination Treatment Modalities 11
Dr. Falk Pharma GmbH – Pipeline Products Glance 12
Dr. Falk Pharma GmbH – Late Stage Pipeline 12
Phase III Products/Combination Treatment Modalities 12
Dr. Falk Pharma GmbH Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Dr. Falk Pharma GmbH – Early Stage Pipeline Products 14
Pre-Clinical Products/Combination Treatment Modalities 14
Dr. Falk Pharma GmbH – Drug Profiles 15
azathioprine 15


List of Figures

List of Tables are also include.



For more related Reports Plz follow The link:

Product Pipeline Review – 2012
http://www.aarkstore.com/search/viewresults.asp?search=Product Pipeline Review – 2012&PubId=&pagenum=1
 

 

Etubics Corporation – Product Pipeline Review – 2012

Faron Pharmaceuticals Oy – Product Pipeline Review – 2012

D. Western Therapeutics Institute, Inc. – Product Pipeline Review – 2012

Deciphera Pharmaceuticals, LLC – Product Pipeline Review – 2012

Dr. Falk Pharma GmbH – Product Pipeline Review – 2012

Eiger BioPharmaceuticals, Inc. – Product Pipeline Review – 2012

e-Therapeutics plc – Product Pipeline Review – 2012

FIT Biotech Oyj – Product Pipeline Review – 2012

Gamida Cell Ltd. – Product Pipeline Review – 2012


 

Search More Reports Related to This Category :
 

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1







For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

H2 2012 || Pipeline || Respiratory Depression – Pipeline Review, H2 2012 || Aarkstore.com

H2 2012 || Pipeline || Respiratory Depression – Pipeline Review, H2 2012 || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it
Global Markets Direct’s, Respiratory Depression - Pipeline Review, H2 2012,
provides an overview of the indication’s therapeutic pipeline.
more...
No comment yet.
Scooped by Lavanya
Scoop.it!

H2 2012 || Pipeline || Viral Infections – Pipeline Review, H2 2012 || Aarkstore.com

H2 2012 || Pipeline || Viral Infections – Pipeline Review, H2 2012 || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Markets Direct’s, Viral Infections - Pipeline Review, H2 2012, provides
an overview of the indication’s therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Viral Infections – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Viral-Infections-Pipeline-Review-H2-2012-228042.html You can also request for sample page of above mention reports on sample@aarkstore.com  

Summary

Global Markets Direct’s, Viral Infections - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Viral Infections, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Viral Infections. Viral Infections - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Viral Infections.
- A review of the Viral Infections products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Viral Infections.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 13
List of Figures 18
Introduction 19
Global Markets Direct Report Coverage 19
Viral Infections Overview 20
Therapeutics Development 21
An Overview of Pipeline Products for Viral Infections 21
Viral Infections Therapeutics under Development by Companies 23
Viral Infections Therapeutics under Investigation by Universities/Institutes 36
Late Stage Products 43
Comparative Analysis 43
Mid Clinical Stage Products 44
Comparative Analysis 44
Early Clinical Stage Products 45
Comparative Analysis 45
Discovery and Pre-Clinical Stage Products 46
Comparative Analysis 46
Viral Infections Therapeutics – Products under Development by Companies 47
Viral Infections Therapeutics – Products under Investigation by Universities/Institutes 63
Companies Involved in Viral Infections Therapeutics Development 78
Bristol-Myers Squibb Company 78
Vical Incorporated 79
United Therapeutics Corporation 80
Shionogi & Co., Ltd. 81


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:


Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1

 

Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012

Respiratory Depression – Pipeline Review, H2 2012

Metastatic Cancer – Pipeline Review, H2 2012

Viral Infections – Pipeline Review, H2 2012

Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
 

  Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

  Diabetes – Pipeline Review, H2 2012

  Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

  Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012

  Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

  Malaria – Pipeline Review, H2 2012

  Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012

  Dermatitis – Pipeline Review, H2 2012

 

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 


For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

H2 2012 || Pipeline || Central Nervous System (CNS) Cancer – Pipeline Review || Aarkstore.com

H2 2012 || Pipeline || Central Nervous System (CNS) Cancer – Pipeline Review || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Markets Direct’s, Central Nervous System (CNS) Cancer - Pipeline Review,
H2 2012, provides an overview of the indication’s therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Central-Nervous-System-CNS-Cancer-Pipeline-Review-H2-2012-228043.html


You can also request for sample page of above mention reports on sample@aarkstore.com  

Summary

Global Markets Direct’s, Central Nervous System (CNS) Cancer - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Central Nervous System (CNS) Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Central Nervous System (CNS) Cancer. Central Nervous System (CNS) Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Central Nervous System (CNS) Cancer.
- A review of the Central Nervous System (CNS) Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.


Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Central Nervous System (CNS) Cancer.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 8
List of Figures 14
Introduction 15
Global Markets Direct Report Coverage 15
Central Nervous System (CNS) Cancer Overview 16
Therapeutics Development 17
An Overview of Pipeline Products for Central Nervous System (CNS) Cancer 17
Central Nervous System (CNS) Cancer Therapeutics under Development by Companies 19
Central Nervous System (CNS) Cancer Therapeutics under Investigation by Universities/Institutes 30
Late Stage Products 43
Comparative Analysis 43
Mid Clinical Stage Products 44
Comparative Analysis 44
Early Clinical Stage Products 45
Comparative Analysis 45
Discovery and Pre-Clinical Stage Products 46
Comparative Analysis 46
Central Nervous System (CNS) Cancer Therapeutics – Products under Development by Companies 47
Central Nervous System (CNS) Cancer Therapeutics – Products under Investigation by Universities/Institutes 60
Companies Involved in Central Nervous System (CNS) Cancer Therapeutics Development 102
Genzyme Corporation 102
Boehringer Ingelheim GmbH 103
F. Hoffmann-La Roche Ltd. 104


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:


Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1

 

Multiple Myeloma (Kahlers Disease) – Pipeline Review, H2 2012

Respiratory Depression – Pipeline Review, H2 2012

Metastatic Cancer – Pipeline Review, H2 2012

Viral Infections – Pipeline Review, H2 2012

Central Nervous System (CNS) Cancer – Pipeline Review, H2 2012
 

  Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

  Diabetes – Pipeline Review, H2 2012

  Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

  Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012

  Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

  Malaria – Pipeline Review, H2 2012

  Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012

  Dermatitis – Pipeline Review, H2 2012

 

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 


For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.
Scooped by Lavanya
Scoop.it!

H2 2012 || Pipeline Review || Cancer Pain – Pipeline Review, H2 2012 || Aarkstore.com

H2 2012 || Pipeline Review || Cancer Pain – Pipeline Review, H2 2012 || Aarkstore.com | 2012 || Product Pipeline Review | Scoop.it

Global Markets Direct’s, Cancer Pain - Pipeline Review, H2 2012, provides an
overview of the indication’s therapeutic pipeline.

Aarkstore.com announces, The Latest  market research report is available in its vast collection:

Cancer Pain – Pipeline Review, H2 2012 http://www.aarkstore.com/reports/Cancer-Pain-Pipeline-Review-H2-2012-227979.html You can also request for sample page of above mention reports on sample@aarkstore.com

Summary

Global Markets Direct’s, Cancer Pain - Pipeline Review, H2 2012, provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Cancer Pain, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Cancer Pain. Cancer Pain - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for Cancer Pain.
- A review of the Cancer Pain products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.


Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for Cancer Pain.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.

Table of contents:

List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Cancer Pain Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Cancer Pain 11
Cancer Pain Therapeutics under Development by Companies 13
Cancer Pain Therapeutics under Investigation by Universities/Institutes 17
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21
Cancer Pain Therapeutics – Products under Development by Companies 22
Cancer Pain Therapeutics – Products under Investigation by Universities/Institutes 23
Companies Involved in Cancer Pain Therapeutics Development 24
Johnson & Johnson 24
BioDelivery Sciences International, Inc. 25


List of Figures

List of Tables are also include.

 

For more related Reports Plz follow The link:


Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2 2012&PubId=&pagenum=1

 

Neutropenia – Pipeline Review, H2 2012

Amyloidosis – Pipeline Review, H2 2012

Human Papillomavirus Infections – Pipeline Review, H2 2012

Cancer Pain – Pipeline Review, H2 2012

Dengue – Pipeline Review, H2 2012

 

  Gastrointestinal Tract Cancer – Pipeline Review, H2 2012

  Diabetes – Pipeline Review, H2 2012

  Chronic Lymphocytic Leukemia (CLL) – Pipeline Review, H2 2012

  Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) – Pipeline Review, H2 2012

  Graft Versus Host Disease (GVHD) – Pipeline Review, H2 2012

  Malaria – Pipeline Review, H2 2012

  Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections – Pipeline Review, H2 2012

  Dermatitis – Pipeline Review, H2 2012

 

 

Search More Reports Related to This Category :

Pharmaceuticals and Healthcare 
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and Healthcare&PubId=&pagenum=1


 


For More details Plz do contact :

Aarkstore Enterprise

Lavanya

Phone:08149852585

Email: enquiry@aarkstore.com

more...
No comment yet.